Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04) [Phase 2]
Completed Phase 2 clinical trial CRY-04 evaluating dose-dense chemotherapy with rituximab for young patients with high-risk diffuse large B-…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: CT-011 MAb in DLBCL Patients Following ASCT [Phase 2]
Phase 2 trial results for the CT-011 monoclonal antibody in diffuse large B-cell lymphoma patients following autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) [Phase 1, Phase 2]
Phase 1/2 safety and tolerability study of SNS01-T in relapsed or refractory B-cell malignancies sponsored by Senesco Technologies. The tria…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating agatolimod sodium in combination with rituximab and Yttrium-90 ibritumomab tiuxetan for adults with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma [Phase 2]
Phase 2 trial from the Children's Oncology Group assesses Rituximab, Rasburicase, and combination chemotherapy in children with newly diagno…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer [Phase 2]
Phase 2 trial evaluating fostamatinib 200 mg for diffuse large B-cell lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL [Phase 3]
A Phase 3 trial comparing doxorubicin and epirubicin in relation to cardiotoxicity in patients with diffuse large B-cell lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 2, Phase 3]
A trial update on lenalidomide for Diffuse Large B-Cell Lymphoma reporting completed phases 2 and 3 with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Dose-adjusted EPOCH-R in MYC Positive DLBCL [Phase 2]
A Phase 2 trial of dose-adjusted EPOCH-R for MYC-positive diffuse large B-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update evaluating the combination of iodine-131 tositumomab with fludarabine phosphate in older patients undergoing autologous…
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of ofatumumab and bortezomib in adults with relapsed CD20-positive lymphomas, including diffuse lar…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma [Phase 3]
A Phase 3 trial evaluating combination chemotherapy for pediatric patients with advanced-stage large cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial [Phase 1]
This report provides Phase 1 safety, pharmacokinetics/pharmacodynamics, and preliminary efficacy data for CT-P10 (rituximab biosimilar) in d…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment [Phase 2]
A Phase 2 trial tested a three-drug combination of bortezomib, liposomal doxorubicin, and rituximab in relapsed or refractory diffuse large …
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma [Phase 2]
This update notes the termination of the Phase 2 trial of MK-2206 in relapsed or refractory diffuse large B-cell lymphoma. No efficacy resul…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: AZD1152 in Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]
Update on Phase 1/2 clinical trials of AZD1152 (barasertib) in diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Imexon for Relapsed Follicular and Aggressive Lymphomas [Phase 2]
Phase 2 clinical trial results for imexon in relapsed follicular lymphoma and various aggressive B-cell lymphomas have been completed with r…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 study evaluating vorinostat with or without isotretinoin in pediatric patients with recurrent or refractory solid tumors, lymphoma, …
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 3]
Phase 3 trial evaluating total-body irradiation with or without fludarabine phosphate followed by donor stem cell transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas [Phase 2]
This is a Phase 2 clinical trial update for relapsed or refractory diffuse large B-cell non-Hodgkin lymphoma that has been terminated with r…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 trial evaluating obatoclax mesylate in combination with vincristine, doxorubicin, and dexrazoxane in pediatric patients with relapse…
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 study of MK-2206 in pediatric patients with recurrent or refractory solid tumors or leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat [Phase 1]
This is a Phase 1b trial update of AMG 655 in combination with bortezomib or vorinostat for lymphomas, including Hodgkin lymphoma and variou…